Foghorn Therapeutics Inc. Shareholders' Equity
Foghorn Therapeutics Inc. (FHTX) had Shareholders' Equity of -$81.04 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent -$81.04M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$76.41M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$108.50M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$89.66M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$81.04M 10-Q · filed 2026-08-06 |
| 2026-03-31 | -$76.41M 10-Q · filed 2026-08-06 |
| 2025-12-31 | -$108.50M 10-Q · filed 2026-08-06 |
| 2025-09-30 | -$89.66M 10-Q · filed 2025-11-05 |
| 2025-06-30 | -$76.66M 10-Q · filed 2026-08-06 |
| 2025-03-31 | -$61.65M 10-Q · filed 2026-08-06 |
| 2024-12-31 | -$45.53M 10-Q · filed 2026-08-06 |
| 2024-09-30 | -$28.29M 10-Q · filed 2025-11-05 |
| 2024-06-30 | -$14.32M 10-Q · filed 2025-11-05 |
| 2024-03-31 | -$97.49M 10-Q · filed 2025-11-05 |
| 2023-12-31 | -$77.19M 10-K · filed 2026-03-11 |
| 2023-09-30 | -$57.39M 10-Q · filed 2024-11-04 |
| 2023-06-30 | -$49.35M 10-Q · filed 2024-11-04 |
| 2023-03-31 | -$24.59M 10-Q · filed 2024-11-04 |
| 2022-12-31 | $112.00K 10-K · filed 2025-03-06 |
| 2022-09-30 | $24.32M 10-Q · filed 2023-11-02 |
| 2022-06-30 | $47.63M 10-Q · filed 2023-11-02 |
| 2022-03-31 | $72.40M 10-Q · filed 2023-11-02 |
| 2021-12-31 | $96.87M 10-K · filed 2024-03-07 |
| 2021-09-30 | $80.98M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $104.19M 10-Q · filed 2022-11-08 |
| 2021-03-31 | $125.16M 10-Q · filed 2022-11-08 |
| 2020-12-31 | $146.19M 10-K · filed 2023-03-09 |
| 2020-09-30 | -$133.32M 10-Q · filed 2021-11-09 |
| 2020-06-30 | -$116.41M 10-Q · filed 2021-11-09 |
| 2020-03-31 | -$101.20M 10-Q · filed 2021-11-09 |
| 2019-12-31 | -$88.02M 10-K/A · filed 2022-08-09 |
| 2019-09-30 | -$73.79M 10-Q · filed 2020-12-04 |
| 2019-06-30 | -$61.28M 10-Q · filed 2020-12-04 |
| 2018-12-31 | -$39.27M 10-K · filed 2021-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |